News
Her goals are to make Piramal Pharma a $2 billion company by 2030 while achieving a 25 per cent EBITDA margin—an aim that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback